EU begins real-time review of Sanofi-GSK Covid-19 vaccine https://ift.tt/eA8V8J

The decision to start the "rolling review" of the vaccine, Vidprevtyn, was based on preliminary results from lab studies and early-stage clinical trials in adults, the European Medicines Agency (EMA).

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3rmWeTA